Search Articles
NEW ORLEANS – In a federal class action, a woman claims she suffered two heart attacks from taking Xanodyne Pharmaceuticals’ drug Darvocet (propoxyphene), which did not even kill pain as it was supposed to, and which Xanodyne knew had been “subject to safety concerns for decades.”
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.